|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號:L397665 |
| 產(chǎn)品名稱:LG 100754 |
| 產(chǎn)品CAS:180713-37-5 |
| 規(guī)格含量:2.5mg |
| 產(chǎn)品價格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
L397665 |
| 名稱: |
LG 100754 |
| 別名: |
(2E,4E,6Z)-3-Methyl-7-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-propoxy-3-naphthalenyl)-2,4,6-octatrienoic Acid; CD 3159; LGD 100754; LGN 100754; UVI 2112 |
| CAS號: |
180713-37-5 |
| 分子式: |
C??H??O? |
| 分子量: |
396.56 |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
LG 100754 is a novel RXR:PPARγ agonist and decreases glucose levels in vivo. |
| 參考文獻(xiàn) |
|
|
|
|